Senores Pharmaceuticals Limited (NSE:SENORES)
India · Delayed Price · Currency is INR 1,178.50
+3.50 (0.30%)
Nov 11, 2026, 1:15 PM IST
Senores Pharmaceuticals Revenue
Senores Pharmaceuticals had revenue of 1.92B INR in the quarter ending September 30, 2026, with 25.41% growth. This brings the company's total for the last twelve months to 7.19B, up 43.00% year-over-year. In the fiscal year ending March 31, 2026, Senores Pharmaceuticals had annual revenue of 6.33B with 58.85% growth. That makes Senores Pharmaceuticals the 24,755th largest company in the world by revenue and 1,554th in India.
Revenue (ttm)
7.19B
Revenue Growth
+43.00%
P/S Ratio
7.53
Revenue / Employee
19.53M
Employees
368
Market Cap
54.27B
Revenue by Geography
- outside India 4.84B 76.5%
- India 1.49B 23.5%
Fiscal year ended Mar 31, 2026 See the full Senores Pharmaceuticals breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 6.33B | 2.34B | 58.85% |
| Mar 31, 2025 | 3.98B | 1.84B | 85.65% |
| Mar 31, 2024 | 2.15B | 1.79B | 507.07% |
| Mar 31, 2023 | 353.37M | 211.67M | 149.38% |
| Mar 31, 2022 | 141.70M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 616.31B |
| Divi's Laboratories | 121.91B |
| Lenskart Solutions | 103.83B |
| Laurus Labs | 78.23B |
| Innova Captab | 17.49B |
| Sahajanand Medical Technologies | 13.55B |
| Artemis Medicare Services | 11.50B |
| Nephrocare Health Services | 11.15B |